Kidney Cancer Clinical Trial

Clinical Trial Finder Kidney Cancer Trials

Healthcare Cost and Resource Utilization Related to Metastatic Renal Cell Carcinoma Treatment With Intravenous and Oral Agents

See Locations Near You

Summary

A retrospective study to evaluate healthcare cost and resource utilization for patients with metastatic renal cell carcinoma who have been treated with IV or oral agents

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Diagnosis with metastatic renal cell carcinoma
Prescription/administration of one of the IV or oral agents examined in the study

Exclusion Criteria:

Patients with other primary cancer diagnosis before RCC diagnosis
Patients with pregnancy or HIV/AIDS

Study is for people with:

Kidney Cancer

Study ID:

NCT02928263

Recruitment Status:

Withdrawn

Sponsor:

Bristol-Myers Squibb

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Bristol-Myers Squibb
Princeton New Jersey, 08540, United States

How clear is this clinincal trial information?

Study is for people with:

Kidney Cancer

Study ID:

NCT02928263

Recruitment Status:

Withdrawn

Sponsor:


Bristol-Myers Squibb

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider